These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16123677)

  • 1. Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012.
    Eshleman SH; Guay LA; Wang J; Mwatha A; Brown ER; Musoke P; Mmiro F; Jackson JB
    J Acquir Immune Defic Syndr; 2005 Sep; 40(1):24-9. PubMed ID: 16123677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.
    Eshleman SH; Guay LA; Mwatha A; Cunningham SP; Brown ER; Musoke P; Mmiro F; Jackson JB
    AIDS Res Hum Retroviruses; 2004 Jun; 20(6):595-9. PubMed ID: 15242535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.
    Jones D; Parkin N; Hudelson SE; Guay LA; Musoke P; Mmiro F; Jackson JB; Eshleman SH
    AIDS Res Hum Retroviruses; 2005 Apr; 21(4):319-24. PubMed ID: 15943576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012).
    Eshleman SH; Guay LA; Mwatha A; Brown ER; Cunningham SP; Musoke P; Mmiro F; Jackson JB
    J Acquir Immune Defic Syndr; 2004 Feb; 35(2):126-30. PubMed ID: 14722443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.
    Flys T; Nissley DV; Claassen CW; Jones D; Shi C; Guay LA; Musoke P; Mmiro F; Strathern JN; Jackson JB; Eshleman JR; Eshleman SH
    J Infect Dis; 2005 Jul; 192(1):24-9. PubMed ID: 15942890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).
    Eshleman SH; Mracna M; Guay LA; Deseyve M; Cunningham S; Mirochnick M; Musoke P; Fleming T; Glenn Fowler M; Mofenson LM; Mmiro F; Jackson JB
    AIDS; 2001 Oct; 15(15):1951-7. PubMed ID: 11600822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.
    Eshleman SH; Hoover DR; Chen S; Hudelson SE; Guay LA; Mwatha A; Fiscus SA; Mmiro F; Musoke P; Jackson JB; Kumwenda N; Taha T
    J Infect Dis; 2005 Jul; 192(1):30-6. PubMed ID: 15942891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.
    Flys TS; Chen S; Jones DC; Hoover DR; Church JD; Fiscus SA; Mwatha A; Guay LA; Mmiro F; Musoke P; Kumwenda N; Taha TE; Jackson JB; Eshleman SH
    J Acquir Immune Defic Syndr; 2006 Aug; 42(5):610-3. PubMed ID: 16773030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission.
    Flys TS; Donnell D; Mwatha A; Nakabiito C; Musoke P; Mmiro F; Jackson JB; Guay LA; Eshleman SH
    J Infect Dis; 2007 Mar; 195(5):711-5. PubMed ID: 17262714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D.
    Church JD; Hudelson SE; Guay LA; Chen S; Hoover DR; Parkin N; Fiscus SA; Mmiro F; Musoke P; Kumwenda N; Jackson JB; Taha TE; Eshleman SH
    AIDS Res Hum Retroviruses; 2007 Jun; 23(6):764-8. PubMed ID: 17604538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.
    Johnson JA; Li JF; Morris L; Martinson N; Gray G; McIntyre J; Heneine W
    J Infect Dis; 2005 Jul; 192(1):16-23. PubMed ID: 15942889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine.
    Flys TS; Mwatha A; Guay LA; Nakabiito C; Donnell D; Musoke P; Mmiro F; Jackson JB; Eshleman SH
    AIDS; 2007 Oct; 21(15):2077-82. PubMed ID: 17885298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV type 1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda.
    Troyer RM; Lalonde MS; Fraundorf E; Demers KR; Kyeyune F; Mugyenyi P; Syed A; Whalen CC; Bajunirwe F; Arts EJ
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):235-50. PubMed ID: 18284323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.
    Fogel J; Hoover DR; Sun J; Mofenson LM; Fowler MG; Taylor AW; Kumwenda N; Taha TE; Eshleman SH
    AIDS; 2011 Apr; 25(7):911-7. PubMed ID: 21487249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda.
    Towler WI; Barlow-Mosha L; Church JD; Bagenda D; Ajuna P; Mubiru M; Musoke P; Eshleman SH
    AIDS Res Hum Retroviruses; 2010 May; 26(5):563-8. PubMed ID: 20455758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.
    Jackson JB; Becker-Pergola G; Guay LA; Musoke P; Mracna M; Fowler MG; Mofenson LM; Mirochnick M; Mmiro F; Eshleman SH
    AIDS; 2000 Jul; 14(11):F111-5. PubMed ID: 10983633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and quantification of minor human immunodeficiency virus type 1 variants harboring K103N and Y181C resistance mutations in subtype A and D isolates by allele-specific real-time PCR.
    Hauser A; Mugenyi K; Kabasinguzi R; Bluethgen K; Kuecherer C; Harms G; Kunz A
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2965-73. PubMed ID: 19433556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-frequency nevirapine resistance at multiple sites may predict treatment failure in infants on nevirapine-based treatment.
    Lehman DA; Wamalwa DC; McCoy CO; Matsen FA; Langat A; Chohan BH; Benki-Nugent S; Custers-Allen R; Bushman FD; John-Stewart GC; Overbaugh J
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):225-33. PubMed ID: 22395670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda.
    Servais J; Lambert C; Karita E; Vanhove D; Fischer A; Baurith T; Schmit JC; Schneider F; Hemmer R; Arendt V
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):279-83. PubMed ID: 15117451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.
    Church JD; Mwatha A; Bagenda D; Omer SB; Donnell D; Musoke P; Nakabiito C; Eure C; Bakaki P; Matovu F; Thigpen MC; Guay LA; McConnell M; Fowler MG; Jackson JB; Eshleman SH
    AIDS Res Hum Retroviruses; 2009 Jul; 25(7):673-7. PubMed ID: 19552593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.